Table 2.

Logistic regression models evaluating the associations between clinical variables and hypertriglyceridemia in APL and non-APL patients.

All patients		Univariable analysis	P-value	Multivariable analysis	P-value
Dependent variable	Independent variable	OR (95% CI)		OR (95% CI)
HTG	Age	1.009(0.998–1.020)	0.130	1.016(1.003–1.029)	0.019
	Gender	1.246(0.889–1.747)	0.202	1.143(0.767–1.705)	0.512
	BMI	1.168(1.097–1.242)	<0.001	1.160(1.087–1.238)	<0.001
	Leukemia type	3.185(2.154–4.710)	<0.001	3.558(2.312–5.477)	<0.001
Leukemia type	Age	1.025(1.013–1.038)	<0.001	1.030(1.012–1.048)	0.001
(non-APL)	Gender	1.259(0.872–1.816)	0.219	1.543(0.906–2.628)	0.110
	BMI	0.980(0.924–1.040)	0.507	0.994(0.910–1.086)	0.897
	TG	0.555(0.446–0.689)	<0.001	0.547(0.414–0.723)	<0.001
	WBC	1.020(1.013–1.027)	<0.001	1.024(1.014–1.034)	<0.001
	PLT	1.014(1.010–1.019)	<0.001	1.019(1.013–1.026)	<0.001
	LDH	1.001(1.000–1.001)	0.001	1.000(1.000–1.001)	0.161
APL patients		Univariable analysis	P-value	Multivariable analysis	P-value
HTG	Age	1.021(1.007–1.035)	0.002	1.026(1.008–1.044)	0.004
	Gender	1.564(1.039–2.354)	0.032	1.222(0.715–2.088)	0.463
	BMI	1.165(1.080–1.257)	<0.001	1.149(1.053–1.254)	0.002
	WBC	1.026(1.012–1.040)	<0.001	1.022(1.005–1.040)	0.011
	LDH	1.001(1.000–1.002)	0.001	1.001(1.000–1.001)	0.122
	transcript isoform

APL, acute promyelocytic leukemia; non-APL, acute myeloid leukemia exclude of APL; HTG group, high triglyceride group ≥ 1.70 (mmol/L); BMI, body mass index; WBC, white blood cell; TG, triglyceride concentration; PLT, platelet count; LDH, lactate dehydrogenase; OR, odds ratios; CI, confidence interval; PML-RARα, promyelocytic leukemia-retinoic acid receptor alpha.